Condition 1: Examining changes in TSH hormone. Condition 2: Examining changes in GH hormone. Condition 3: Examining changes in body composition indices. Condition 4: Examining changes in cognitive function. Hyperfunction of pituitary gland, unspecified Hyperfunction of pituitary gland, unspecified Other obesity due to excess calories Mental disorder, not otherwise specified
Conditions
Interventions
Intervention 1: Intervention group: Resistance training: Each participant’s 6 repetition maximum (6 RM) will use to estimate their 1 RM using the Brzycki formula (%1RM = 102.78–2.78 * repetitions). Th
16–20 RM with 30 seconds rest between sets, in weeks 6–10
between 8–14 RM, with between 30–120 seconds inter-set rest, and in weeks 11–16
between 6 and 12 RM with 30–120 seconds inter-set rest. Intervention 2: Intervention group: Aerobic training: The intensity of the sessions was progressively will increase from moderate to vigorous ac
20 minutes at 65–75% of estimated max HR
weeks 4–6
30 mins at 65–75%, weeks 7–12
30 minutes at 70–80%, weeks 13–16
35 minutes at 70–80%. The principal activities will use in aerobic are variations in straight line and multi directional jogging/running, with obstacles such as cones, hoops and speed ladders. S
Sponsors
Islamic Azad University Aliabad Katoul Branch
Eligibility
Sex/Gender
All
Age
11 Years to 15 Years
Inclusion criteria
Inclusion criteria: Being between 11 and 15 years old Studying in one of the first secondary schools of Aliabad Katul city Consent of the family for their child's participation in the trial Ability to participate in physical exercises
Exclusion criteria
Exclusion criteria: Taking a specific drug Suffering from specific physical or mental diseases Drug abuse lack of education
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Error number. Timepoint: At the beginning of the first phase of the study, the beginning of the second phase of the study and its end. Method of measurement: computer modified Stroop color-word test.;Body fat mass. Timepoint: At the beginning of the first phase of the study and its end. Method of measurement: FM formula.;Fat-free body mass. Timepoint: At the beginning of the first phase of the study and its end. Method of measurement: PFFM formula.;Waist circumference. Timepoint: At the beginning of the first phase of the study and its end. Method of measurement: tape measure.;TSH blood levels. Timepoint: Measurement of TSH blood levels at the beginning of the second phase study (before the start of the intervention) and 16 weeks later. Method of measurement: laboratory kit.;GH blood levels. Timepoint: Measurement of GH blood levels at the beginning of the second phase study (before the start of the intervention) and 16 weeks later. Method of measurement: laboratory kit.;BMI. Timepoint: At the beginning of the first phase of the study and its end. Method of measurement: BMI Formula.;Short term working memory. Timepoint: At the beginning of the first phase of the study, the beginning of the second phase of the study and its end. Method of measurement: digit span forward test.;Amount of daily physical activity. Timepoint: At the beginning of the first phase of the study. Method of measurement: International Physical Activity Questionnaire (IPAQ) – Long Form.;Body fat percentage. Timepoint: At the beginning of the first phase of the study and its end. Method of measurement: Jackson-Pollock Formula.;Lean body mass percentage. Timepoint: At the beginning of the first phase of the study and its end. Method of measurement: Jackson Pollock's complementary formula.;Processing speed. Timepoint: At the beginning of the first phase of the study, the beginning of the second phase of the study and its end. Method of measurement: digit-symbol coding test.;Reaction time. Timepoin | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid profile. Timepoint: At the beginning of the second phase the study (before the start of the intervention) and 16 weeks later. Method of measurement: laboratory kit.;Glucose. Timepoint: At the beginning of the second phase the study (before the start of the intervention) and 16 weeks later. Method of measurement: laboratory kit.;Height. Timepoint: At the beginning of the first phase of the study, at the beginning of the second phase of the study and its end. Method of measurement: tape measure.;Weight. Timepoint: At the beginning of the first phase of the study, at the beginning of the second phase of the study and its end. Method of measurement: digital Balance.;Blood pressure. Timepoint: At the beginning of the first phase of the study, at the beginning of the second phase of the study and its end. Method of measurement: Sphygmomanometer.;Muscle strength. Timepoint: At the beginning of the first phase of the study, at the beginning of the second phase of the study and its end. Method of measurement: 1 RM Formula.;Aerobic power. Timepoint: At the beginning of the first phase of the study, at the beginning of the second phase of the study and its end. Method of measurement: submaximal treadmill test.;Personality measurement. Timepoint: At the beginning of the first phase of the study and its end. Method of measurement: Eysenck Eysenck Personality Questionnaire (JEPQ) Questionnaire (JEPQ).;Academic motivation. Timepoint: At the beginning of the first phase of the study and its end. Method of measurement: Harter's standard academic motivation questionnaire.;Moods. Timepoint: At the beginning of the first phase of the study and its end. Method of measurement: Brunel Mood Scale Questionnaire.;General Health. Timepoint: At the beginning of the first phase of the study and its end. Method of measurement: General Health Questionare (GHQ-28).;Internet Addiction. Timepoint: At the beginning of the first phase of the study and its end. Method of measurement: Young's Inte | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReza Rezaeeshirazi
Islamic Azad University Aliabad Katoul Branch
Outcome results
None listed